Using CRISPR for the ‘smaller wins,’ like making chemotherapy less toxic – STAT
“The future of gene-editing is full of big things — big breakthroughs, big ethical questions, and big business — but we must not overlook the value of smaller wins. Those, in fact, can be big wins for patients.” Read more from our director’s op-ed in STAT News
